title: Neuro-Sweet disease mimicking recurrent anaplastic astrocytoma associated with therapy-related myelodysplastic syndrome: a case report.
authors.affiliation: Department of Neurosurgery, Kanazawa University Hospital, Kanazawa, Japan.
authors.forename: Yu
authors.initials: Y
authors.lastname: Shimizu
authors.forename: Takuya
authors.initials: T
authors.lastname: Watanabe
authors.forename: Mitsutoshi
authors.initials: M
authors.lastname: Nakada
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Hayashi
authors.forename: Yasuhito
authors.initials: Y
authors.lastname: Hamaguchi
authors.forename: Naomi
authors.initials: N
authors.lastname: Sugimori
authors.forename: Jun-ichiro
authors.initials: J
authors.lastname: Hamada
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001254:Astrocytoma / Q000175:diagnosis*; D001921:Brain / Q000473:pathology; D001932:Brain Neoplasms / Q000175:diagnosis*; D002277:Carcinoma / Q000175:diagnosis*; D059248:Chemoradiotherapy / Q000009:adverse effects; D003875:Drug Eruptions / Q000473:pathology; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology*; D015376:Nimustine / Q000009:adverse effects / Q000627:therapeutic use; D016463:Sweet Syndrome / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology*
chemical_list: D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D015376:Nimustine; D008775:Methylprednisolone